These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33303079)

  • 21. Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease.
    Lee MT; Mahtta D; Alam M; Ullah W; Nasir K; Hanif B; Virani SS
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):559-570. PubMed ID: 33565901
    [No Abstract]   [Full Text] [Related]  

  • 22. Comorbidities in inflammatory bowel disease: a call for action.
    Argollo M; Gilardi D; Peyrin-Biroulet C; Chabot JF; Peyrin-Biroulet L; Danese S
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):643-654. PubMed ID: 31171484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous and arterial disease in inflammatory bowel disease.
    Tan VP; Chung A; Yan BP; Gibson PR
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1095-113. PubMed ID: 23662785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review.
    Łykowska-Szuber L; Rychter AM; Dudek M; Ratajczak AE; Szymczak-Tomczak A; Zawada A; Eder P; Lesiak M; Dobrowolska A; Krela-Kaźmierczak I
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory bowel disease and coronary artery disease.
    Sappati Biyyani RS; Fahmy NM; Baum E; Nelson KM; King JF
    Indian J Gastroenterol; 2009; 28(1):28-30. PubMed ID: 19529899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory bowel disease and risk of coronary heart disease.
    Rungoe C; Nyboe Andersen N; Jess T
    Trends Cardiovasc Med; 2015 Nov; 25(8):699-704. PubMed ID: 25912602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis and Inflammatory Bowel Disease.
    Cottone M; Sapienza C; Macaluso FS; Cannizzaro M
    Dig Dis; 2019; 37(6):451-457. PubMed ID: 31079092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of inflammatory and genetic biomarkers for cardiovascular disease prevention, categorization, and treatment.
    Mewborn EK; Wright DB; Wicks MN
    J Am Assoc Nurse Pract; 2023 Jul; 35(7):404-412. PubMed ID: 37260280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.
    Eppinga H; Poortinga S; Thio HB; Nijsten TEC; Nuij VJAA; van der Woude CJ; Vodegel RM; Fuhler GM; Peppelenbosch MP
    Inflamm Bowel Dis; 2017 Oct; 23(10):1783-1789. PubMed ID: 28617755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement.
    Zanoli L; Mikhailidis DP; Bruno RM; Abreu MT; Danese S; Eliakim R; Gionchetti P; Katsanos KH; Kirchgesner J; Koutroubakis IE; Kucharzik T; Lakatos PL; Nguyen GC; Papa A; Vavricka SR; Wilkinson IB; Boutouyrie P
    Angiology; 2020 Sep; 71(8):689-697. PubMed ID: 32292048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atherosclerotic vascular disease in the autoimmune rheumatologic woman.
    Kurmann RD; Mankad R
    Clin Cardiol; 2018 Feb; 41(2):258-263. PubMed ID: 29480591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Increased risk of venous thromboembolism and arterial cardiovascular events in patients with inflammatory bowel disease].
    Lund Kristensen S; Ahlehoff O; Lindhardsen J; Gislason G; Nielsen OH; Hansen PR
    Ugeskr Laeger; 2012 Nov; 174(48):3003-6. PubMed ID: 23195352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of 10-year Atherosclerotic Cardiovascular Disease Risk among Adults Aged 40-79 Years in China: a Nationally Representative Survey.
    Zhang M; Jiang Y; Wang LM; Li YC; Huang ZJ; Li JH; Zhou MG; Zhao WH;
    Biomed Environ Sci; 2017 Apr; 30(4):244-254. PubMed ID: 28494834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
    Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
    Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014.
    Fan W; Philip S; Granowitz C; Toth PP; Wong ND
    Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
    Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
    J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review.
    Stone NJ; Smith SC; Orringer CE; Rigotti NA; Navar AM; Khan SS; Jones DW; Goldberg R; Mora S; Blaha M; Pencina MJ; Grundy SM
    J Am Coll Cardiol; 2022 Mar; 79(8):819-836. PubMed ID: 35210038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives.
    Wu MF; Xu KZ; Guo YG; Yu J; Wu Y; Lin LM
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):739-748. PubMed ID: 31655942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.